NCT02635464 - Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions

Chronic Ischemic Cardiomyopathy

Interventions

BIOLOGICAL

hUC-MSCs+Injectable collagen scaffold+CABG

Patients underwent Coronary Artery Bypass Surgery (CABG) with 10\^8 allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) in collagen scaffold injecting in the infarct region.

BIOLOGICAL

hUC-MSCs+CABG

Patients underwent Coronary Artery Bypass Surgery (CABG) with 10\^8 allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) injecting in the infarct region.

PROCEDURE

CABG

Patients underwent CABG alone.

Trial Locations (1)

210008

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing